| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/11/2004 | US6733751 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 05/11/2004 | US6733748 Chronic lymphocytic leukemia treatment |
| 05/11/2004 | US6733747 Prosthetic grafts |
| 05/11/2004 | US6733746 Culture product; cell differentiation |
| 05/07/2004 | CA2448481A1 A cell therapy method for the treatment of tumors |
| 05/07/2004 | CA2411397A1 Reovirus for the treatment of ral-mediated cellular proliferative disorders |
| 05/06/2004 | WO2004037851A2 Colostrinin and peptides thereof as modulators of intracellular signaling molecules and inhibitors of apoptosis |
| 05/06/2004 | WO2004037321A2 Immunotherapy of cancer through controlled cell lysis |
| 05/06/2004 | WO2004037288A1 Agent eleveting dendritic cell precursor level in blood |
| 05/06/2004 | WO2004037280A1 Angiogenesis inducer |
| 05/06/2004 | WO2004037202A2 Gb virus c and methods of treating viral infections |
| 05/06/2004 | WO2004037195A2 Treatment of diabetes |
| 05/06/2004 | WO2004037188A2 Cardiac muscle regeneration using mesenchymal stem cells |
| 05/06/2004 | WO2004037182A2 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | WO2004030652A3 Dosage form having an inner core and at least two coating layers |
| 05/06/2004 | WO2004028441A3 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 05/06/2004 | WO2004027051A3 Use of a fusion polypeptide for obtaining pluripotent nonembryonic stem cells |
| 05/06/2004 | WO2004017895A3 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 05/06/2004 | WO2004015113A3 Albumin-fused ciliary neurotrophic factor |
| 05/06/2004 | WO2004003562A3 Oncolytic viruses as phenotyping agents for neoplasms |
| 05/06/2004 | WO2003105893A3 Probiotic therapies using lactobacillus reuteri |
| 05/06/2004 | WO2003105891A3 Use of hec1 antagonists in the treatment of proliferative disorders and cancer |
| 05/06/2004 | WO2003103389A3 Cryopreservation of haptenized tumor cells |
| 05/06/2004 | WO2003099318A3 Pancreas-specific proteins |
| 05/06/2004 | WO2003090695A3 TREATMENT OF α-GALACTOSIDASE A DEFICIENCY |
| 05/06/2004 | WO2003050502A9 Prospective identification and characterization of breast cancer stem cells |
| 05/06/2004 | WO2003010314A3 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 05/06/2004 | US20040087890 Device and method for perfusing peritoneal dialyzing fluid |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087555 Phosphohalohydrins, process for the production thereof and use thereof |
| 05/06/2004 | US20040087532 Vaccine comprising antigen presenting cells loaded with at least two tumor antigens and/or tumor antigen derived peptides |
| 05/06/2004 | US20040087528 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia |
| 05/06/2004 | US20040087510 Cardiovascular diseases and disorders; sustained delivery of nitric oxide |
| 05/06/2004 | US20040087485 Educated nkt cells and their uses in the treatment of immune-related disorders |
| 05/06/2004 | US20040087018 Using vitamin d3, cytokine, antibody and dexamethasone mixture to identify and treat inflammatory or autoimmune diseases |
| 05/06/2004 | US20040087016 Using cyclin dependent kinase inhibitors to return differentiated cells to pluripotent state; tissue engineering and organ transplantation |
| 05/06/2004 | US20040087004 Process for producing a culture of antrodia camphorata and product obtained thereby |
| 05/06/2004 | US20040086846 Using bacterial artificial chromosomes to propagate/replicate viral nucleotide sequences; gene therapy and genetic vaccines |
| 05/06/2004 | US20040086533 For inhibiting bacterial invasion via intestinal barrier containing live Bacillus subtilis cells as an active ingredient |
| 05/06/2004 | US20040086518 Universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 05/06/2004 | US20040086517 Porous, implantable device containing a fibrous support and at least one antigen |
| 05/06/2004 | US20040086497 Cell-matrix structure for implantation stably expressing a gene encoding at least one biological modifier to stop or regress excessive tissue proliferation |
| 05/06/2004 | US20040086494 Immune privileged cells for delivery of proteins and peptides |
| 05/06/2004 | US20040086493 That can be polymerized in contact with living cells and tissues, and in a very short time period that can be polymerized in contact with living cells and tissues, and in a very short time period. |
| 05/06/2004 | US20040086492 Achieves a remarkable improvement in the effect of the treatment of a tumor such as cancer by administering activated lymphocytes over a specific period of time before or after the implementation of photodynamic therapy |
| 05/06/2004 | US20040086491 Administering either a prebiotic or a probiotic directly into the intestinal tract of a mammal |
| 05/06/2004 | US20040086487 Prevention or the treatment of congestive heart failure or myocardial ishchemia by administering a sphingosine kinase, or an analogue, fragment, or derivative thereof |
| 05/06/2004 | US20040086485 Viral vector sequences in plasmid form delivered in-vivo to generate vector producing cells |
| 05/06/2004 | EP1415662A1 Homing autologous cells to a target zone in tissue for delivery of translocation stimulators |
| 05/06/2004 | EP1415661A1 Homing of embryonic stem cells to a target zone in tissue for delivery of translocation stimulators |
| 05/06/2004 | EP1415660A1 Homing donor cells to a target zone in tissue for delivery of translocation stimulators |
| 05/06/2004 | EP1415656A1 Lactobacillus strains capable of preventing diarrhoea caused by rotaviruses |
| 05/06/2004 | EP1415655A1 Immunotherapy for humans |
| 05/06/2004 | EP1414996A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 05/06/2004 | EP1414994A2 Microorganisms and cells for diagnosis and therapy of tumors |
| 05/06/2004 | EP1414954A2 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 05/06/2004 | EP1414949A1 Cell and transgenic animal modelling human antigenic presentation and their uses |
| 05/06/2004 | EP1414948A2 Inhibition of apoptosis process and improvement of cell performance |
| 05/06/2004 | EP1414947A2 Multipotent stem cells from peripheral tissues and uses thereof |
| 05/06/2004 | EP1414946A2 Dendritic cells and the uses thereof in screening cellular targets and potential drugs |
| 05/06/2004 | EP1414944A2 Methods for ex vivo propagation of somatic stem cells |
| 05/06/2004 | EP1414853A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/06/2004 | EP1414845A2 Human secreted proteins |
| 05/06/2004 | EP1414492A1 Method for treating multiple myeloma |
| 05/06/2004 | EP1414486A2 Use of glp-2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 05/06/2004 | EP1414480A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 05/06/2004 | EP1414368A2 Eb matrix production from fetal tissues and its use for tissue repair |
| 05/06/2004 | EP1414305A2 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance |
| 05/06/2004 | EP1369122A4 Anticancer agent |
| 05/06/2004 | EP1181027B1 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/06/2004 | EP1047395B1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
| 05/06/2004 | EP1019067B1 Methods of using emu oil and active fractions thereof as an insect repellent |
| 05/06/2004 | EP0957944B1 Bone matrix, the utilization thereof, therapeutic preparation and kit |
| 05/06/2004 | EP0910451B1 Biological fluid filter device comprising a leukocyte depletion medium |
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | EP0776161B1 Use of a viral vector encoding a cytochrome p450 gene in combination with a chemotherapeutic agent for selectively destroying neoplastic cells |
| 05/06/2004 | EP0729297A4 Hepatoblasts and method of isolating same |
| 05/06/2004 | DE10305082A1 MIA-2 Protein MIA-2 protein |
| 05/06/2004 | DE10249600A1 Invertebrate-based medicinal preparation, encases live caterpillar in bread dough, for release in large intestine to stimulate immune system and bring about healing |
| 05/06/2004 | CA2505597A1 Agent elevating dendritic cell precursor level in blood |
| 05/06/2004 | CA2503457A1 Apparatus and method for immunotherapy of a cancer through controlled cell lysis |
| 05/06/2004 | CA2502960A1 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | CA2502453A1 Angiogenesis inducer |
| 05/06/2004 | CA2501677A1 Treatment of diabetes |
| 05/05/2004 | CN1494590A Modified thrombopoietin with reduced immunogenicity |
| 05/05/2004 | CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 05/05/2004 | CN1494450A Manual processing systems and methods for providing blood components conditioned for pathogen inactivation |
| 05/05/2004 | CN1494430A Modified protamine with reduced immunogenicity |
| 05/05/2004 | CN1494429A Aguatic animal treatment method and composition containing pimenta extract |
| 05/05/2004 | CN1494427A Medicament for treating asthma |
| 05/05/2004 | CN1494426A Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
| 05/05/2004 | CN1494374A Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 05/05/2004 | CN1493684A New acid resistant and cholate resistant lactobacillus isolated strain having reducing and assimilating cholesterol ability |
| 05/05/2004 | CN1493327A Chinese medicine for treating leucocythemia and its preparation method and application. |
| 05/05/2004 | CN1493322A Chinese medicine composition for treating tumour |
| 05/05/2004 | CN1493305A Intestine micro ecological regulating agent |
| 05/05/2004 | CN1493304A Method of extracting mixed propolis using supercritical fluid separation |
| 05/05/2004 | CN1493303A Extraction method of scorpion active protein liquid |
| 05/05/2004 | CN1493302A Rabbit skin containing bioactive substance and its use |
| 05/05/2004 | CN1493224A Dear horn chewing piece |